1
Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
Condition(s):Metastatic Prostate CancerLast Updated:September 10, 2007Unknown status
Hide Studies Not Open or Pending
Condition(s):Metastatic Prostate CancerLast Updated:September 10, 2007Unknown status
Condition(s):Prostatic NeoplasmsLast Updated:December 21, 2007Unknown status
Condition(s):Breast Cancer; Bone MetastasesLast Updated:November 24, 2015Completed
Condition(s):Prostate CancerLast Updated:December 19, 2023Completed
Condition(s):Urinary Bladder NeoplasmsLast Updated:January 24, 2022Completed
Condition(s):Prostate CancerLast Updated:December 17, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.